FILING ANALYSIS · WEDNESDAY, JULY 29
Solvay Sa 0NZR — RNS
neutral
Solvay's Q2 results show a 7.4% organic decline in underlying net sales and a 19.5% organic decrease in underlying EBITDA, but the company confirms its full-year guidance, expecting underlying EBITDA between €770 million and €850 million and free cash flow of at least €200 million. The confirmed guidance and anticipated restart of its Saudi Arabian peroxides plant in Q3 may provide some support to
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →